Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Elizabeth R. Plimack | Researchclopedia

Back to researchers

Elizabeth R. Plimack

Fox Chase Cancer Center ORCID

762

Works

48,352

Citations

79

h-index

254

i10-index

Research Topics

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Renal cell carcinoma treatment

Affiliations

University of North Carolina at Chapel Hill2011–2011

Novartis (Switzerland)2018–2018

Fox Chase Cancer Center2009–2025

Roswell Park Comprehensive Cancer Center2014–2016

St. Jude Children's Research Hospital2017–2017

Top Works

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Robert J. Motzer,Bernard Escudier,et al.

20155,843 citations

Urinary and Genital Oncology Studies

Multiple and Secondary Primary Cancers

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma

Robert J. Motzer,Nizar M. Tannir,et al.

20184,544 citations

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini,Elizabeth R. Plimack,et al.

20193,323 citations

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy

Răzvan Cristescu,Robin Mogg,et al.

20182,284 citations

Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial

Padmanee Sharma,Margitta Retz,et al.

20171,734 citations

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

Woonyoung Choi,Sima P. Porten,et al.

20141,718 citations

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

James L. Mohler,Emmanuel S. Antonarakis,et al.

20191,556 citations

First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

Arjun Vasant Balar,Daniel Castellano,et al.

20171,330 citations

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Christos E. Kyriakopoulos,Yu‐Hui Chen,et al.

20181,085 citations